Appili Therapeutics Inc.

Appili Therapeutics is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel medicines to treat infectious diseases and address medical countermeasures. The company is dedicated to solving life-threatening infections by identifying urgent unmet needs and advancing a portfolio of anti-infective programs, including vaccines and therapeutics. Headquartered in Halifax, Nova Scotia, Appili operates as a portfolio-driven organization. Its pipeline includes FDA-approved assets like LIKMEZ™ (metronidazole oral suspension) and various clinical-stage candidates targeting biodefense threats and resistant bacterial/parasitic infections. The company frequently collaborates with government agencies and research partners to advance its development programs.